Lisa Durkin

1.5k total citations
32 papers, 626 citations indexed

About

Lisa Durkin is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Lisa Durkin has authored 32 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 13 papers in Genetics. Recurrent topics in Lisa Durkin's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (7 papers). Lisa Durkin is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (7 papers). Lisa Durkin collaborates with scholars based in United States, Italy and Germany. Lisa Durkin's co-authors include Eric D. Hsi, Juraj Bodo, Xiaoxian Zhao, Jeffrey Lin, Mitchell R. Smith, Danyu Sun, Sarah L. Ondrejka, Mien Sho, Debra T. Chao and Darren C. Phillips and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Lisa Durkin

31 papers receiving 620 citations

Peers

Lisa Durkin
Julia Steinhilber Germany
Claudiu Cotta United States
Emanuela Carlotti United Kingdom
Alejandra Martínez‐Trillos Spain
Joan H. Admirand United States
Laurens P. Kil Netherlands
Vundavalli V. Murty United States
Lisa Kujawski United States
Katherine I. Lin United States
Paloma Bárcena Spain
Julia Steinhilber Germany
Lisa Durkin
Citations per year, relative to Lisa Durkin Lisa Durkin (= 1×) peers Julia Steinhilber

Countries citing papers authored by Lisa Durkin

Since Specialization
Citations

This map shows the geographic impact of Lisa Durkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Durkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Durkin more than expected).

Fields of papers citing papers by Lisa Durkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Durkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Durkin. The network helps show where Lisa Durkin may publish in the future.

Co-authorship network of co-authors of Lisa Durkin

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Durkin. A scholar is included among the top collaborators of Lisa Durkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Durkin. Lisa Durkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kaseb, Hatem, Valeria Visconte, Genevieve M. Crane, et al.. (2023). The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non‐AML myeloid neoplasms. Genes Chromosomes and Cancer. 62(10). 573–580. 2 indexed citations
3.
Gurnari, Carmelo, Simona Pagliuca, Lisa Durkin, et al.. (2021). Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Blood. 137(26). 3685–3689. 54 indexed citations
4.
Zhao, Xiaoxian, et al.. (2020). Decreased BIM expression in BCL2-negative follicular lymphoma: a potential mechanism for resistance to apoptosis. Human Pathology. 107. 1–8. 4 indexed citations
5.
Zhao, Xiaoxian, Juraj Bodo, Lisa Durkin, et al.. (2020). Inhibition of cyclin‐dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphoma. SHILAP Revista de lepidopterología. 1(1). 161–169. 5 indexed citations
6.
Gu, Xiaorong, Rita Tohmé, Benjamin Tomlinson, et al.. (2020). Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network. Leukemia. 35(4). 1023–1036. 64 indexed citations
7.
Patel, Nisha, Lisa Durkin, Juraj Bodo, & Eric D. Hsi. (2019). Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas. American Journal of Clinical Pathology. 153(5). 646–655. 8 indexed citations
8.
Purcell, James W., Jonathan A. Hickson, Melvin Fox, et al.. (2018). LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates. Cancer Research. 78(14). 4059–4072. 136 indexed citations
9.
Goyal, Tanu, Beenu Thakral, Sa A. Wang, et al.. (2017). T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas. American Journal of Clinical Pathology. 149(2). 164–171. 13 indexed citations
10.
Guo, Ling, Juraj Bodo, Lisa Durkin, & Eric D. Hsi. (2017). Evaluation of PD1/PDL1 Expression and Their Clinicopathologic Association in EBV-associated Lymphoproliferative Disorders in Nonimmunosuppressed Patients. Applied immunohistochemistry & molecular morphology. 27(2). 101–106. 6 indexed citations
11.
Bodo, Juraj, et al.. (2016). Performance of a Commercially Available MAL Antibody in the Diagnosis of Primary Mediastinal Large B-Cell Lymphoma. The American Journal of Surgical Pathology. 41(2). 189–194. 20 indexed citations
12.
Bodo, Juraj, et al.. (2016). CAL2 Immunohistochemical Staining Accurately IdentifiesCALRMutations in Myeloproliferative Neoplasms. American Journal of Clinical Pathology. 146(4). 431–438. 9 indexed citations
13.
Shi, Yang, Xiaoxian Zhao, Lisa Durkin, Heesun J. Rogers, & Eric D. Hsi. (2016). Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Human Pathology. 52. 173–178. 3 indexed citations
14.
Ebrahem, Quteba, Reda Z. Mahfouz, Lisa Durkin, et al.. (2015). Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML and Pre-Clinical In Vivo Proof of Principle of Rational Solutions to Extend Response. Blood. 126(23). 678–678. 6 indexed citations
15.
Banks, Peter M., Angela M. B. Collie, Christopher Lanigan, et al.. (2015). Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma. Leukemia & lymphoma. 57(7). 1640–1648. 12 indexed citations
16.
Nakashima, Megan O., Lisa Durkin, Juraj Bodo, et al.. (2014). Utility and Diagnostic Pitfalls of SOX11 Monoclonal Antibodies in Mantle Cell Lymphoma and Other Lymphoproliferative Disorders. Applied immunohistochemistry & molecular morphology. 22(10). 720–727. 15 indexed citations
17.
Ondrejka, Sarah L., et al.. (2013). MYD88 L265P Somatic Mutation. American Journal of Clinical Pathology. 140(3). 387–394. 40 indexed citations
18.
Chao, Debra T., Mien Sho, Donghee Choi, et al.. (2012). Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb. Journal of Cancer Research and Clinical Oncology. 139(2). 315–325. 28 indexed citations
19.
Ondrejka, Sarah L., et al.. (2012). Phospho-ERKTHR202/Tyr214 Is Overexpressed in Hairy Cell Leukemia and Is a Useful Diagnostic Marker in Bone Marrow Trephine Sections. The American Journal of Surgical Pathology. 37(2). 305–308. 12 indexed citations
20.
Bodo, Juraj, Lisa Durkin, & Eric D. Hsi. (2009). Quantitative In Situ Detection of Phosphoproteins in Fixed Tissues Using Quantum Dot Technology. Journal of Histochemistry & Cytochemistry. 57(7). 701–708. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Steinhilber Breakdown of academic impact, for papers by Claudiu Cotta Breakdown of academic impact, for papers by Emanuela Carlotti Breakdown of academic impact, for papers by Alejandra Martínez‐Trillos Breakdown of academic impact, for papers by Joan H. Admirand Breakdown of academic impact, for papers by Laurens P. Kil Breakdown of academic impact, for papers by Vundavalli V. Murty Breakdown of academic impact, for papers by Lisa Kujawski Breakdown of academic impact, for papers by Katherine I. Lin Breakdown of academic impact, for papers by Paloma Bárcena
Rankless by CCL
2026